MOODY NATIONAL BANK TRUST DIVISION

Bank

Position in NVO — Novo Nordisk A S

CIK 1092903 GALVESTON, TX

Position in NVO

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$544,214

+$319,785 QoQ

Shares Held

11,352

+251.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#684

of 1,348 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MOODY NATIONAL BANK TRUST DIVISION holds $28,796,627 across 12 Drug Manufacturers - General names. NVO ranks #8 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,596	$7,911,440
2	JNJ	Johnson & Johnson	27,945	$7,097,191
3	ABBV	AbbVie Inc.	15,834	$3,984,467
4	MRK	Merck & Co., Inc.	20,628	$2,650,697
5	PFE	Pfizer Inc	83,566	$2,012,268
6	GILD	Gilead Sciences, Inc.	12,186	$1,539,578
7	BMY	Bristol Myers Squibb Co	25,150	$1,449,142
8	NVO	Novo Nordisk A S This page	11,352	$544,214

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$544,214	11,352	+251.2%	Shares	Defined	2026-07-07
2025-03-31	$224,429	3,232	+72.9%	Shares	Defined	2025-04-04
2024-09-30	$222,540	1,869	+18.1%	Shares	Defined	2024-10-03
2024-06-30	$225,956	1,583	-24.9%	Shares	Defined	2024-07-03
2022-06-30	$234,782	2,107	-74.0%	Shares	Defined	2022-07-07
2022-03-31	$900,281	8,107	0.0%	Shares	Defined	2022-04-12
2021-12-31	$907,984	8,107	-86.0%	Shares	Defined	2022-01-13
2021-09-30	$5,578,852	58,107	+0.0%	Shares	Defined	2021-10-07
2021-06-30	$4,866,618	58,095	0.0%	Shares	Defined	2021-08-05
2021-03-31	$3,916,764	58,095	0.0%	Shares	Defined	2021-04-14
2020-12-31	$4,057,935	58,095	-0.6%	Shares	Defined	2021-03-04
2020-09-30	$4,058,252	58,451	-2.0%	Shares	Defined	2020-10-08
2020-06-30	$3,907,190	59,670	+0.6%	Shares	Defined	2020-07-10
2020-03-31	$3,569,498	59,294	—	Shares	Defined	2020-04-17
No filing history on record for this holder in this stock.